Publication Name	World Journal of Nephrology
Manuscript ID	27100
Country	Canada

Received	2016-05-10 08:52
Peer-Review Started	2016-05-11 18:40
To Make the First Decision	2016-06-07 13:51
Return for Revision	2016-06-14 10:40
Revised	2016-08-02 20:52
Second Decision	2016-10-21 16:13
Accepted by Journal Editor-in-Chief	2016-10-21 16:57
Accepted by Company Editor-in-Chief	2016-10-27 17:13
Articles in Press	2016-10-27 17:13
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-04-27 15:28
Publish the Manuscript Online	2017-05-04 18:19

ISSN	2220-6124 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Urology & Nephrology
Manuscript Type	Case Control Study
Article Title	Any link of gout disease control among hypertensive patients and onset of end-stage renal disease? Results from a population-based study
Manuscript Source	Unsolicited Manuscript
All Author List	Sylvie Perreault, Javier Nuevo, Scott Baumgartner and Robert Morlock
Funding Agency and Grant Number
Corresponding Author	Sylvie Perreault, BPharm, PhD, Full Professor, Faculty of Pharmacy, University of Montreal, Case Postale 6128, Succursale Centre-Ville, Montreal, QC H3C 3J7, Canada. sylvie.perreault@umontreal.ca
Key Words	Allopurinol; End-stage renal disease; Gout; Hyperuricemia; Medication adherence; Serum uric acid
Core Tip	The question of whether serum uric acid has a pathogenic role in the onset and progression of chronic kidney disease (CKD) remains unanswered. Hyperuricemia and gout is common in CKD, and treatment adherence in gout patients is suboptimal and therefore a therapeutic challenge. Our population-based study assessed the impact of gout disease control on the risk of end stage renal disease (ESRD). Our study suggest that adherence to allopurinol of ≥ 80% as a proxy for gout control is associated with a significant, 65% reduction in the risk of ESRD onset.
Publish Date	2017-05-04 18:19
Citation	Perreault S, Nuevo J, Baumgartner S, Morlock R. Any link of gout disease control among hypertensive patients and onset of end-stage renal disease? Results from a population-based study. World J Nephrol 2017; 6(3): 132-142
URL	http://www.wjgnet.com/2220-6124/full/v6/i3/132.htm
DOI	http://dx.doi.org/10.5527/wjn.v6.i3.132

Full Article (PDF)	WJN-6-132.pdf
Full Article (Word)	WJN-6-132.doc
Manuscript File	27100-Review.docx
Answering Reviewers	27100-Answering reviewers.pdf
Audio Core Tip	27100-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	27100-Conflict-of-interest statement.pdf
Copyright License Agreement	27100-Copyright assignment.pdf
Institutional Review Board Approval Form or Document	27100-Institutional review board statement.pdf
Peer-review Report	27100-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	27100-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	27100-Scientific misconduct check.pdf
Scientific Editor Work List	27100-Scientific editor work list.pdf